Avoiding delays in emergent treatment of generalized pustular psoriasis

被引：1
作者：
Elston, Dirk M. [1 ]
机构：
[1] Med Univ SC, Dept Dermatol & Dermatol Surg, MSC 578,135 Rutledge Ave,11th Floor, Charleston, SC 29425 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 04期
关键词：
biologics; consensus statement; generalized pustular psoriasis; GPP pathogenesis; IL-36; pathway; National Psoriasis Foundation;
D O I：
10.1016/j.jaad.2023.07.1049
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：705 / 706
页数：2
相关论文
共 6 条
  • [1] Management of adult generalized pustular psoriasis using biologics: A systematic review
    Abduelmula, Abrahim
    Rankin, Brian D.
    Sood, Siddhartha
    Georgakopoulos, Jurgie R.
    Mufti, Asfandyar
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal H.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 417 - 419
  • [2] Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study
    Burden, A. D.
    Okubo, Y.
    Zheng, M.
    Thaci, D.
    van de Kerkhof, P.
    Hu, N.
    Quaresma, M.
    Thoma, C.
    Choon, S. E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2023, 32 (08) : 1279 - 1283
  • [3] Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis (GPP) Flares
    Choon, Siew Eng
    Lebwohl, Mark G.
    Turki, Hamida
    Zheng, Min
    Burden, A. David
    Li, Ling
    Quaresma, Manuel
    Thoma, Christian
    Bachelez, Herve
    [J]. DERMATOLOGY, 2023, 239 (03) : 345 - 354
  • [4] Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study
    Elewski, Boni E.
    Lebwohl, Mark G.
    Anadkat, Milan J.
    Barker, Jonathan
    Ghoreschi, Kamran
    Imafuku, Shinichi
    Mrowietz, Ulrich
    Li, Ling
    Quaresma, Manuel
    Thoma, Christian
    Bachelez, Herve
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 36 - 44
  • [5] Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial
    Warren, Richard B.
    Reich, Adam
    Kaszuba, Andrzej
    Placek, Waldemar
    Griffiths, Christopher E. M.
    Zhou, Jihao
    Randazzo, Bruce
    Lizzul, Paul
    Gudjonsson, Johann E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : 161 - 169
  • [6] Genetics of Generalized Pustular Psoriasis: Current Understanding and Implications for Future Therapeutics
    Yang, Syuan-Fei
    Lin, Min-Huei
    Chou, Pei-Chen
    Hu, Sheng-Kai
    Shih, Sin-Yi
    Yu, Hsin-Su
    Yu, Sebastian
    [J]. GENES, 2023, 14 (06)
1